FSLBX
Price
$183.72
Change
+$2.63 (+1.45%)
Updated
Jun 6 closing price
Net Assets
1.31B
RYFNX
Price
$90.95
Change
+$1.13 (+1.26%)
Updated
Jun 6 closing price
Net Assets
31.27M
Interact to see
Advertisement

FSLBX vs RYFNX

Header iconFSLBX vs RYFNX Comparison
Open Charts FSLBX vs RYFNXBanner chart's image
Fidelity Select Brokerage & Inv Mgmt
Price$183.72
Change+$2.63 (+1.45%)
VolumeN/A
Net Assets1.31B
Rydex Financial Services A
Price$90.95
Change+$1.13 (+1.26%)
VolumeN/A
Net Assets31.27M
FSLBX vs RYFNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSLBX vs. RYFNX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLBX is a Buy and RYFNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSLBX has more cash in the bank: 1.31B vs. RYFNX (31.3M). RYFNX pays higher dividends than FSLBX: RYFNX (0.81) vs FSLBX (0.70). FSLBX was incepted earlier than RYFNX: FSLBX (40 years) vs RYFNX (21 years). RYFNX (1.69) is less costly to investors than FSLBX (0.69). RYFNX is a more actively managed with annual turnover of: 119.00 vs. FSLBX (16.00). FSLBX has a lower initial minimum investment than RYFNX: FSLBX (0) vs RYFNX (2500). FSLBX annual gain was more profitable for investors over the last year : 25.97 vs. RYFNX (21.41). FSLBX return over 5 years is better than : 132.10 vs. RYFNX (42.63).
FSLBXRYFNXFSLBX / RYFNX
Total Expense Ratio0.691.6542%
Annual Report Gross Expense Ratio0.691.6941%
Fund Existence40 years21 years-
Gain YTD-0.2793.539-8%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.31B31.3M4,173%
Annual Yield % from dividends0.700.8186%
Returns for 1 year25.9721.41121%
Returns for 3 years72.377.24999%
Returns for 5 years132.1042.63310%
Returns for 10 years149.8173.99202%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TIXT2.850.19
+7.14%
TELUS International (Cda)
ZNTL1.520.05
+3.40%
Zentalis Pharmaceuticals
REAX4.200.08
+1.94%
Real Brokerage (The)
INFA24.13N/A
N/A
Informatica
SNOA3.32-0.05
-1.48%
Sonoma Pharmaceuticals Inc